Cargando…

Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP

OBJECTIVE: Human T cell lymphotropic virus 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive, neurological disease. Chronic activation of CD8(+) T cells, as evidenced by increased spontaneous lymphoproliferation and HTLV‐1‐specific cytotoxic T cells, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enose‐Akahata, Yoshimi, Oh, Unsong, Ohayon, Joan, Billioux, Bridgette Jeanne, Massoud, Raya, Bryant, Bonita R., Vellucci, Ashley, Ngouth, Nyater, Cortese, Irene, Waldmann, Thomas A., Jacobson, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689682/ https://www.ncbi.nlm.nih.gov/pubmed/31402625 http://dx.doi.org/10.1002/acn3.50820

Ejemplares similares

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2021)

HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
por: Anderson, Monique R, et al.
Publicado: (2014)

Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Massoud, Raya, et al.
Publicado: (2014)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2018)

Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection.
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1–Associated Neurologic Disease
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2021)

Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2016)

Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease
por: Nozuma, Satoshi, et al.
Publicado: (2021)

Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases
por: Pleet, Michelle L., et al.
Publicado: (2023)

Through the looking glass: CNS imaging findings in HAM/TSP
por: Massoud, Raya
Publicado: (2014)

Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations
por: Brunetto, Giovanna S., et al.
Publicado: (2014)

High Expression of CD244 and SAP Regulated CD8(+) T Cell Responses of Patients with HTLV-I Associated Neurologic Disease
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2009)

Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2012)

BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy
por: Massoud, Raya, et al.
Publicado: (2014)

Quantitative differences in antibody responses between normal donors HAM/TSP patients, asymptomatic carriers, and ATL patients from Jamaica: can they be used to estimate risk of disease?
por: Akahata, Yoshimi, et al.
Publicado: (2011)

HAM/TSP introduction: systematic review of HAM/TSP clinical trials
por: Anderson, Rebecca, et al.
Publicado: (2014)

Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Liu, Winston, et al.
Publicado: (2014)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients
por: Sousa, Alessandra de Paula A, et al.
Publicado: (2015)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

Clinical features of familial HAM/TSP
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

T cell receptor repertoire analysis in HTLV-1-associated diseases
por: Clauze, Annaliese, et al.
Publicado: (2022)

The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2023)

Recent epidemiologic trends of HAM/TSP in Japan
por: Matsuzaki, Toshio, et al.
Publicado: (2011)

Evaluation of clinical outcome measures for HAM/TSP
por: Kikuchi, Takayuki, et al.
Publicado: (2015)

HAM/TSP and major depression: the role of age
por: Boa-Sorte, Ney, et al.
Publicado: (2015)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2013)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

Clinical subtype of HAM/TSP based on clinical course and laboratory findings
por: Yamano, Yoshihisa, et al.
Publicado: (2011)

Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019
por: Araujo, Abelardo, et al.
Publicado: (2021)

Characterization of glycans of CD4+T cells in HAM/TSP
por: Kodama, Daisuke, et al.
Publicado: (2014)

Contribution of galvanic vestibular stimulation for the diagnosis of HAM/TSP
por: Cunha, Luciana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ud4luh051jbsnt8ehimncu0h94